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ABSTRACT
Budd–Chiari syndrome (BCS) encompasses a group of disorders caused by the obstruction to the hepatic venous outflow 
at the level of the small or large hepatic veins, the inferior vena cava, or any combination thereof. Clinical manifestation 
of the subacute form is characterized by supramesocolic abdominal discomfort, abdominal distension, fever, and lower 
limbs edema. Imaging work-up with hepatic Doppler ultrasound and abdominal computed tomography (CT) enables the 
diagnosis in the majority of cases. Treatment comprises long-term anticoagulation associated with measures that attempt 
to re-establish the flow in the thrombosed vessel (thrombolysis or angioplasty) or through the venous blood flow bypasses 
(transjugular intrahepatic portosystemic shunt or surgical bypass); however, the outcome is often dismal. The authors 
report the case of a 37-year-old woman presenting a 2-month history of dyspeptic complaints and abdominal distention. 
Fever was present at the beginning of symptoms. The laboratory work-up disclosed mild hepatic dysfunction, and the 
ultrasound showed evidence of chronic liver disease. Despite a thorough etiologic investigation, diagnosis was missed and, 
therefore, management could not be directed towards the physiopathogenetic process. The outcome was characterized 
by portal hypertension and esophageal varices bleeding. The patient died and the autopsy findings were characteristic of 
BCS, although an abdominal CT, close to death, had showed signs consistent with this diagnosis. The authors highlight 
the importance of knowledge of this entity, the diagnostic methods, and the multidisciplinary approach. BCS should be 
considered whenever investigating etiology for chronic or acute hepatopathy.
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CASE REPORT
A 37-year-old, previously healthy, Caucasian 
female patient sought medical care, complaining of 
a 2-month history of abdominal discomfort, nausea, 
vomiting, lack of appetite, weight loss (6 kg in 
2 months), and fever at the beginning of the symptoms. 
She denied alcohol consumption, tobacco smoking, 
use of medications or illicit drugs, contraceptives, 
previous hemotransfusion, or surgical procedure. 
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The physical examination showed a well-looking 
patient with normal hemodynamic parameters, who 
weighed 69 kg, and had a body mass index of 29. 
The abdomen was mildly distended, the liver was 
palpable until 4 cm below the right costal margin, and 
Traube’s space was dull on percussion. The remaining 
physical examination was normal. The initial laboratory 
work-up is shown in Table 1.
The abdominal ultrasound examination showed 
an enlarged liver with diffuse heterogeneous and 
coarsened echotexture. Portal and hepatic veins as 
well as the gall bladder, the biliary tree, and the spleen 
were normal. A small amount of free fluid was present 
within the abdominal cavity. The abdominal computed 
tomography (CT) showed an enlarged liver and caudate 
lobe hypertrophy causing a narrowing of the inferior 
vena cava. Liver parenchyma showed heterogeneous 
attenuation coefficient with some nodules sketches. 
A small amount of free fluid was present in the 
abdominal cavity.
The patient did not attend the scheduled follow-up 
and 4 months later she entered the emergency room 
presenting hematemesis. The physical examination 
revealed normal hemodynamic parameters and 
neurological status; however, moderate ascites and 
right pleural effusion were detected. The upper 
digestive endoscopy disclosed esophageal varices and 
hypertensive gastropathy; the former were tied off with 
elastic bands. On this occasion the hepatic Doppler 
ultrasound showed the venous portal system without 
signs of thrombosis with monophasic waveform and 
normal peak systolic velocity. The left and middle 
hepatic veins were pervious with normal flow direction, 
but the right hepatic vein, as well as the gastric and 
splenic veins, could not be accessed.
Continuing the investigation of the hepatopathy, 
the iron profile tests, ceruloplasmin, and alpha-1 
antitrypsin were normal. The protein electrophoresis 
showed a polyclonal hypergamaglobulinemia. 
The antinuclear antibody test was negative, and 
the search for anti-liver cytosol, antiparietal cell, 
anti-mitochondrial, anti-LKM-1, and anti-smooth 
muscle antibodies was also negative.
The patient was submitted to a liver biopsy, the 
histological findings of which were at first interpreted 
as moderate active liver cirrhosis without cholestasis, 
iron deposition, or steatosis. She was referred to a 
liver transplantation service, but was considered not 
eligible because her MELD (model for end-stage liver 
disease) score was 12, which is under the limit for 
liver transplantation in Brazil in 2015. A diagnosis of 
cryptogenic cirrhosis was rendered.
The clinical outcome was troublesome, and 
the patient developed a refractory ascites, requiring 
Table 1. Initial laboratory investigation
Exam Result RV Exam Result RV
Hemoglobin 13.1 12.3–15.3 g/dL ALT 31 9–36 U/L
Hematocrit 40.5 36.0–45.0% AST 46 10–31 U/L
Leukocytes 6.44 4.4–11.3 × 103/mm3 AP 120 10–100 U/L
Segmented 59 45–70% γGT 177 2–30 U/L
Eosinophils 2 1–4% LDH 272 120–246 U/L
Lymphocytes 30 18–40% TP 7.8 6.0–8.0 g/dL
Monocytes 9 2–9% Albumin 4.1 3.0–5.0 g/dL
Platelets 141 150–400 × 103/mm3 TB 1.28 0.3–1.2 mg/dL
INR 1.45 1 Amylase 87 30–118 U/L
Urea 19 5–25 mg/dL Lipase 43 13–60 U/L
Creatinine 0.4 0.4–1.3 mg/dL CRP 9 < 5 mg/L
Potassium 4.3 3.5–5.0 mEq/L anti-HIV Negative
Sodium 139 136–146 mEq/L anti-HCV Negative
Glucose 93 < 99 mg/dL anti-HBV (serology) Negative
ALT = alanine aminotransferase. AP = alkaline phosphatase. AST = aspartate aminotransferase. CRP = C-reactive protein. 
γGT = gamma-glutamyl transpeptidase. LDH = lactate dehydrogenase. RV = reference value. TB = total bilirubin. TP = total protein.
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repeated paracentesis. After 9 months since the 
beginning of symptoms, she had lost 12 kg (6 kg of 
which were lost in the last 2 months) and presented 
weakness, vomiting, abdominal pain, and dyspnea. 
She was hospitalized with severe hyponatremia. At this 
time, another abdominal CT was performed, which 
revealed heterogeneity of the attenuation coefficient 
of the liver parenchyma, narrowing of the intra hepatic 
portion of the inferior vena cava, thrombosis of the 
portal vein, and non-contrasting hepatic veins besides a 
possible thrombosis of the anomalous hepatic vein that 
was not filled in by contrast (Figure 1). The examination 
of the peritoneal fluid ruled out the diagnosis of 
spontaneous bacterial peritonitis, but, unfortunately, 
acute renal failure ensued and the patient died after 
5 days due to septic shock of an unidentified site.
AUTOPSY FINDINGS
The autopsy revealed an emaciated female corpse 
with moderate ascites and bilateral pleural effusions.
The liver was enlarged, micronodular, and 
intensely reddened. Collapsing areas of parenchymal 
loss were seen (Figure 2A). Hepatic veins could not 
be individualized due to organizing macroscopic 
thrombosis, which could be seen on the liver cut 
surface (Figure 2B). Thrombosis was not identified in 
the inferior vena cava or the portal vein. On microscopic 
examination, the liver was cirrhotic (Figure 2C), 
with mild-to-moderate inflammatory infiltrate with 
lymphocytes, histiocytes, and some neutrophils 
(Figure 2D).
The central and portal veins showed multiple 
organizing thrombosis (Figure 3A–C), sometimes 
with near total obliteration of the portal branches 
(Figure 3D). Areas of recent and organizing hepatocyte 
necrosis were seen throughout the liver. The gallbladder 
and the biliary tract were normal, except for a moderate 
ductular reaction related to cirrhosis.
The spleen was enlarged and congested while 
uncomplicated esophageal varices could be noted 
on the distal half of the esophagus. The bowels were 
grossly purplish and friable. Histological examination 
confirmed transmural small bowel infarction with local 
thrombosis and bacterial proliferation (Figure 4A and B).
While the heart and pericardium were normal, the 
lungs were friable, reddish, boggy, and heavy. Upon 
microscopic examination, the lungs showed intense 
congestion, edema, septic emboli and multifocal 
bronchopneumonia (Figure 4C and D).
Figure 1. Abdominal computed tomography—portal phase. A – Attenuation coefficient heterogeneity of the 
hepatic parenchyma. B – Portal vein (PV) thrombosis compression of the inferior vena cava (IVC) by the caudate 
lobe. C – Unfilled anomalous hepatic vein. D – Narrowing of the inferior vena cava. AHV = anomalous hepatic vein. 
HA = hepatic artery.
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Figure 2. A and B – Gross examination of the cut surface of the liver (formalin fixed) showing micronodular aspect 
with collapsing areas (dark purple areas). The arrow in B shows an organizing thrombus in the segmental hepatic 
vein. C – Photomicrography of the liver showing nodular transformation (cirrhosis) and an organizing thrombus in a 
central vein (arrow) (Masson trichrome, 12.5X). D –Photomicrography of the liver showing moderate inflammation 
in fibrous septa mimicking an ordinary inflammatory cirrhosis (H&E, 100X).
Other signs of sepsis and shock were detected in 
the pancreas (focal ischemic pancreatitis), kidneys (acute 
tubular necrosis), and adrenals (ischemic changes). 
Focal capillary thrombosis was found in the lungs, 
which was consistent with disseminated intravascular 
coagulation, and reactive erythrophagocytosis in the 
lymph nodes. The bone marrow showed reactive 
hypercellularity but no signs of dysplasia, malignancy, 
or hematological disorder were found.
In summary, the autopsy findings were consistent 
with veno-portal cirrhosis due to Budd–Chiari syndrome 
(BCS) with complicated portal hypertension, final 
bowel infarction, and septic shock.
In fact, revis ion of the l iver biopsy sl ides 
confirmed the impression of cirrhosis with moderate 
inflammation. However, s igns of complicated 
venous outflow blockage disease, such as sinusoidal 
dilatation and lobular necrosis, were present. Some 
portal and central veins showed luminal obliteration 
and fibrosis, which were unnoticed at the first analysis 
(Figure 5 A–D).
DISCUSSION
BCS is a rare hepatic disorder resulting from 
the complete or incomplete hepatic venous outflow 
obstruction that may take place either in the small and 
large hepatic veins and/or the inferior vena cava leading 
to liver damage and portal hypertension.1,2 Despite the 
scarcity of epidemiological data, the presentation 
seems to differ according to geographical differences. 
In Western countries, women in the third or fourth 
decade of life are most affected, and involvement of 
the hepatic veins predominates.3-5 In 1845, the English 
physician, George Budd, first published the triad of 
abdominal pain, hepatomegaly, and ascites associated 
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with hepatic venous outflow obstruction, in his 
treatise “Diseases of the Liver.” In 1899, the Austrian 
pathologist Hans Chiari described the histopathological 
features and, since then, the syndrome has been coined 
Budd–Chiari syndrome, although the disorder had 
been observed already and mentioned by Karl F. von 
Rokitansky (1808–1878).6,7
BCS is divided into two types. The “secondary 
type” is when a lesion (a benign or malignant tumor, 
trauma, an abscess, or a cyst), which originates outside 
the veins, causes an obstruction to the hepatic blood 
outflow (compression or invasion).1 The “primary 
type” is when the obstruction (thrombosis or phlebitis) 
occurs within the vessel. Primary BCS occurs because 
of prothrombotic factors, either hereditary or acquired, 
which are identified in up to 87% of cases. Multiple 
causes in the same patient have been increasingly 
recognized and are present in 25% of cases.3,8,9 
Myeloproliferative diseases particularly are the most 
common causes, present in nearly 50% of cases 
of primary BCS, and among them polycythemia 
vera accounts for 10–40% of cases, followed by 
thrombophilia due to factor V Leiden mutation, 
prothrombin-gene mutation, antiphospholipid 
antibody syndrome, inherited deficiencies of protein C, 
protein S, and antithrombin III.2,3,10 Lupus anticoagulant 
or anti-beta-2 glycoprotein 1 antibodies may be found 
in smaller proportion along with other possible risk 
factors, such as paroxysmal nocturnal hemoglobinuria, 
Behçet’s disease, hypereosinophil ic syndrome, 
granulomatous venulitis, and ulcerative colitis.1,3
The relative risk of the development of BCS 
caused by contraceptives is up to 2.4% (similar to the 
relative risk of other site’s thrombosis); contraceptives 
are identified in half of the women with the diagnosis 
of BCS.2,9 Pregnancy and the puerperium are also 
considered predisposing factors. However, the 
likelihood of the development of BCS is increasingly 
Figure 3. Photomicrography of the liver. A – Organizing thrombus in a segmental hepatic vein (same as in Figure 2B) 
(H&E,100X). B – Recanalized thrombus in a segmental hepatic vein (H&E, 100X). C – Abnormal portal tract with 
extensive fibrosis and sclerosis or portal vein (H&E, 200X). D – Abnormal portal tract with fibrosis, inflammation and 
sclerosis or portal vein (arrow) (H&E, 200X).
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recognized when these factors are associated with 
other underlying thrombophilia.2,9
The extent and rapidity of hepatic vein occlusion, 
as well as the development of collateral circulation 
are responsible for the wide spectrum of clinical 
presentation, ranging from a fulminant form to a 
chronic disease, and indeed, from asymptomatic 
to full symptomatic cases. Fever, abdominal pain, 
abdominal distension, ascites, hepatomegaly, and 
lower limbs edema are the most common signs and 
symptoms.2,3,8,10 The subacute form, which is the 
most common presentation, is characterized by an 
insidious onset, generally within 3 months, clinical 
features of vague discomfort in the epigastrium or 
right hypochondrium, and mild ascites that increases 
with the disease progression (when portal hypertension 
ensues).8,9 Because the BCS is often missed in the 
differential diagnosis, patients with clinical and 
laboratory findings consistent with hepatopathy are 
mistakenly diagnosed.2
The laboratory profile is non-specific. In the 
subacute form, mild elevation of hepatic enzymes, 
a decrease in serum albumin, a high serum-ascites 
albumin gradient, and a protein determination of 
usually more than 2.5 g/dL in the ascitic fluid. Hepatic 
failure, as well as higher determination of hepatic 
enzymes, may be present in the acute and fulminant 
forms.1,2
Imaging examination is fundamental for the 
diagnosis.2,3 Once suspected, the diagnostic approach 
should start with the hepatic Doppler ultrasound 
that has an accuracy of up to 85%.11 This technique 
allows the evaluation of the hepatic veins and the 
inferior vena cava blood flows that may be decreased, 
reversed, or absent in the BCS.5,11–13 Stenosis or dilation 
of these veins and the caudate lobe hypertrophy are 
Figure 4. Photomicrography of other autopsy findings. A – Small bowel hemorrhagic infarct with bacterial colonies 
(arrow) and venous thrombi (arrowheads) (H&E, 200X). B – Small bowel mural infarction with extensive acute 
inflammation and thrombosis (H&E, 200X). C – Septic embolus in the lung with fibrin, neutrophils, and bacterial 
colonies (H&E, 200X). D – Hematogenous pneumonia with bacterial colony in alveolar capillaries (H&E, 400X).
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other signs12 (the latter, although non-specific, is 
present in 75% of cases).1 In chronic cases, collateral 
veins are observed in the hepatic veins and/or inferior 
vena cava.1,2 Other imaging methods may be helpful 
in the diagnostic work-up, such as the CT that may 
show the presence of regenerative nodules, a delay 
of filling or an absence of the contrast medium in 
the hepatic veins and/or inferior vena cava, as well as 
unequal parenchymal contrast enhancement (called 
heterogeneous attenuation coefficient of the hepatic 
parenchyma) between the peripheral and central region 
of the liver.12 However, 50% of the cases may show 
false-positive results, reinforcing the importance of 
the correlation with the Doppler ultrasound results.1,2,9
In the case reported herein, the first abdominal CT 
did not clearly identify signs that could elucidate the 
etiology of the hepatopathy. The Doppler ultrasound, 
which was undertaken late in the course of this 
patient’s disease, showed normal blood flow through 
the left and middle hepatic veins as well as through 
the portal system. In this examination, the right 
hepatic vein was not accessed, which should have 
been highly considered as an obstruction of the blood 
flow, but as the gastric and splenic veins were not 
identified either, we dare considered that this fact 
may have interfered with the correct interpretation of 
the method. Magnetic resonance imaging is usually 
helpful in the differentiation of acute and chronic cases, 
and it helps to better evaluate the involvement of the 
inferior vena cava.13 The gold standard examination, for 
the diagnosis of BCS, is the hepatic venography that 
should be performed when the suspicion is high and 
any other imaging examination has failed to elucidate 
the problem.2,13,14
Hepatic biopsy is rarely necessary and is indicated 
in doubtful cases.2,13 The histopathological features 
Figure 5. Photomicrography of the liver biopsy. A – Organizing collapsed areas with fibrosis and chronic inflammation. 
B – Sinusoidal dilatation. C – Recent focus or hepatic necrosis (collapse). D –Portal tract with organized portal vein 
thrombosis. (All images H&E, 100X).
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comprise indirect findings of BCS, as congestion, 
sinusoidal dilation, hepatocytes loss, centrilobular 
fibrosis and bridging fibrosis. Intrahepatic portal vein 
thrombosis may be seen in advanced cases associated 
with large fibrosis of the portal tracts. Nodular 
regenerative hyperplasia and macroregenerative 
nodules are present in longstanding cases.1,15 These 
findings vary according to the duration and the 
intensity of obstruction.11,13 Diagnosis, quite often, 
requires an experienced pathologist. Unfortunately, 
the liver biopsy report of this patient did not mention 
any direct or indirect finding of BCS, but only cirrhosis. 
However, on the biopsy’s revision, features consistent 
with BCS could be found.9 Unfortunately, the biopsy 
was performed late in the course of the disease, 
most probably because of the lack of follow-up, even 
though, at this advanced stage, some relief could 
have been offered to the patient, despite the gloomy 
prognosis.
Clinical suspicion of BCS is quite often challenging 
due to its rarity and the variety of clinical presentations.2 
Around 10–25% of BCS cases are idiopathic3 and in 
these cases, no risk factors are present, which can 
somehow influence clinical reasoning and a focused 
investigation. Incomplete or partial obstruction of the 
inferior vena cava and the hepatic vein branch may 
have an asymptomatic course and may be overlooked.16
Once the diagnosis is established, indefinite 
anticoagulation is prescribed for the cases associated 
with non-curable thrombophilia, as in other venous 
thrombosis territories.1 Recently, transjugular 
intrahepatic portosystemic shunts have been 
increasingly used, mostly when vessel clearing by 
fibrinolysis, or angioplasty, or the anticoagulation did 
not succeed.17 Another therapeutic option for the 
decompression of the hepatic circulation remains in the 
portosystemic shunting at the expense of decreased 
portal venous inflow. However, this approach is related 
to high morbimortality. Liver transplantation may be 
considered in refractory cases to the standard or usual 
therapy, and for fulminant cases.
The treatment of BCS is far from an easy task and, 
like the diagnosis, often requires quite a multidisciplinary 
team. Preventing the progression to hepatic insufficiency 
should be the goal of the management of the patients 
with BCS, but complications related to the cirrhosis 
and/or portal hypertension also takes part of the 
management of BCS.1,12 Patients, submitted to hepatic 
outflow clearing, present a favorable outcome and 
prognosis, showing a 5-year and 10-year survival rate 
of 80% and 75%, respectively.1,9,16
The case reported herein illustrates a typical case 
of BCS with the Western presentation form that, 
unfortunately, was only diagnosed at autopsy. The final 
event, in this patient, was also due to thrombotic events. 
The necrosis of the small intestine and subsequent 
spread of infection, which was clearly demonstrated 
at autopsy, was the cause of death. We considered 
this misdiagnosis as a consequence of a series of 
inaccuracies, which relied on the interpretation of the 
diagnostic methods, and on clinical failure to gather 
all the medical staff involved in the patient’s care. 
Although BCS is not among the most common causes 
of cirrhosis, this diagnosis should always be taken into 
account either in acute or chronic hepatopathy,2,18 and 
yet many diagnoses are still missed.
This case report demonstrates the importance in 
strongly pursuing the hepatic cirrhosis etiology, since, 
in some cases, it is possible to substantially change the 
outcome and prognosis.
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